TP53 and myeloproliferative neoplasm: A recent study analyzed the impact of TP53* in MPN patients and, although it is common that at least one somatic TP53* allele is transcribed in patient cells, the authors did not find a direct association between TP53 inactivation and HU resistance or blast transformation [33].